ReviewRadiology. Imaging cancer2025
Percutaneous Ablation of Thyroid Cancer.
Review in Radiology. Imaging cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Safety and efficacy of radiofrequency ablation for papillary thyroid carcinoma adjacent to the thyroid capsule.Frontiers in oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Percutaneous ablation of benign thyroid nodules has become a widely accepted alternative to surgery. There has also been increasing use of percutaneous ablation in thyroid cancer. However, there are important differences between ablating benign and malignant nodules. Proper patient selection is critical for achieving good outcomes. While the field is rapidly evolving, there are fundamental principles that must be understood. The purpose of this review is to overview thyroid cancer biology, describe safe and effective techniques for treating thyroid cancers, and discuss which patients would benefit most from percutaneous ablation treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.